Target intelligence / Profile preview

UQCRFS1 divergent transcript (UQCRFS1-DT)

Target
UQCRFS1-DT
Molecular classification
Long non-coding RNA (lncRNA), Divergent transcript
01

Overview

**UQCRFS1 divergent transcript (UQCRFS1-DT)** is a long non-coding RNA (lncRNA) gene found in the human genome and is classified as a divergent transcript, meaning it is a non-coding RNA located within 300–500 nucleotides of a protein-coding gene—specifically, the UQCRFS1 gene[7][9]. Divergent lncRNAs such as UQCRFS1-DT are typically transcribed from the opposite strand near a protein-coding gene and may play regulatory roles at the transcriptional, post-transcriptional, or chromatin remodeling level, though specific functions for UQCRFS1-DT have not been reported[7][9]. There is no evidence that UQCRFS1-DT acts as a classical therapeutic target such as a receptor, enzyme, transporter, or channel, nor are there known roles in disease, drug interactions, or use as a biomarker[7][9][5]. Its alternative names include CTB-32O4.2, CTB-32O4.3, and CTB-32O4.4[5][7]. **Summary of findings and targets:** - **UQCRFS1-DT** is distinct from the protein-coding gene **UQCRFS1** (which codes for a mitochondrial electron transport chain subunit)[1][7]. - UQCRFS1-DT is a lncRNA (not a protein), with no established function, disease role, or direct therapeutic relevance at this time[7][9]. - No drugs or mechanisms of action are associated with this transcript. - No errors, ambiguity, or misspelling were identified for this target.

Other names
CTB-32O4.2CTB-32O4.3CTB-32O4.4
02

Biological functions

Unknownmay involve transcriptional regulation as a lncRNA
03

Disease associations

Unknown

Beyond the preview

Go deeper on UQCRFS1 divergent transcript (UQCRFS1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UQCRFS1 divergent transcript (UQCRFS1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call